The Cancer Letter

Inside information on cancer research and drug development

Vol.
2
No.
4
January 23, 1976Jan 23, 1976
Free
DOWNLOAD THE PDF

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

NCI Budget for FY 1977 Would Halt New Research

Congressman Obey Attacks NCI for Not Supporting Basic Research

Nutrition RFPs Will Really Be Grants, Gori Says

Cyclamate Committee Finds No Proof Of Carcinogenicity

Login

Site license subscribers:
Log in with your IP | Register a sponsored account